Application 090636

Type
ANDA
Sponsor
HETERO LABS LTD III

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001TENOFOVIR DISOPROXIL FUMARATETENOFOVIR DISOPROXIL FUMARATETABLET;ORAL300MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
16714-820Tenofovir Disoproxil FumarateTenofovir Disoproxil FumarateNorthStar RxLLCANDACurrent
31722-535Tenofovir Disoproxil FumarateTenofovir Disoproxil FumarateCamber Pharmaceuticals, Inc.ANDACurrent
42291-800Tenofovir Disoproxil FumarateTenofovir Disoproxil FumarateAvKARE, Inc.ANDACurrent
42291-800Tenofovir Disoproxil FumarateTenofovir Disoproxil FumarateAvKAREANDACurrent
42291-800Tenofovir Disoproxil FumarateTenofovir Disoproxil FumarateAvKAREANDACurrent
70518-2151Tenofovir Disoproxil FumarateTenofovir Disoproxil FumarateREMEDYREPACK INC.ANDACurrent
70518-2151Tenofovir Disoproxil FumarateTenofovir Disoproxil FumarateREMEDYREPACK INC.ANDACurrent
70518-2151Tenofovir Disoproxil FumarateTenofovir Disoproxil FumarateREMEDYREPACK INC.ANDACurrent
70518-2151Tenofovir Disoproxil FumarateTenofovir Disoproxil FumarateREMEDYREPACK INC.ANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
9282ORIG2010-04-05